Morgan Stanley’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.38M Buy
198,463
+136,106
+218% +$644K ﹤0.01% 4974
2025
Q4
$301K Buy
62,357
+61,318
+5,902% +$205K ﹤0.01% 5754
2025
Q3
$2.09K Buy
1,039
+187
+22% +$179 ﹤0.01% 7297
2025
Q2
$512 Sell
852
-1,316
-61% -$675 ﹤0.01% 7446
2025
Q1
$585 Sell
2,168
-15,029
-87% -$4.98K ﹤0.01% 7349
2024
Q4
$8.94K Sell
17,197
-20,680
-55% -$50.4K ﹤0.01% 6845
2024
Q3
$123K Sell
37,877
-8,299
-18% -$26.9K ﹤0.01% 5922
2024
Q2
$139K Sell
46,176
-74,338
-62% -$269K ﹤0.01% 5836
2024
Q1
$560K Sell
120,514
-59,706
-33% -$288K ﹤0.01% 5263
2023
Q4
$746K Buy
180,220
+56,883
+46% +$168K ﹤0.01% 5442
2023
Q3
$370K Sell
123,337
-79,400
-39% -$236K ﹤0.01% 5305
2023
Q2
$499K Sell
202,737
-145,137
-42% -$401K ﹤0.01% 5214
2023
Q1
$786K Sell
347,874
-140,865
-29% -$486K ﹤0.01% 4999
2022
Q4
$1.71M Buy
488,739
+196,129
+67% +$1.72M ﹤0.01% 4557
2022
Q3
$10.8M Sell
292,610
-22,627
-7% -$627K ﹤0.01% 2877
2022
Q2
$5.99M Buy
315,237
+49,172
+18% +$1.07M ﹤0.01% 3596
2022
Q1
$7.18M Sell
266,065
-307,256
-54% -$6.35M ﹤0.01% 3284
2021
Q4
$12.9M Buy
573,321
+123,980
+28% +$2.76M ﹤0.01% 2643
2021
Q3
$11.8M Buy
449,341
+422,982
+1,605% +$11.3M ﹤0.01% 2700
2021
Q2
$844K Buy
26,359
+25,205
+2,184% +$875K ﹤0.01% 5184
2021
Q1
$41K Sell
1,154
-10,462
-90% -$366K ﹤0.01% 6438
2020
Q4
$373K Sell
11,616
-1,828
-14% -$62.8K ﹤0.01% 5252
2020
Q3
$506K Sell
13,444
-32,443
-71% -$1.25M ﹤0.01% 4638
2020
Q2
$2.05M Buy
45,887
+45,111
+5,813% +$1.91M ﹤0.01% 3569
2020
Q1
$26K Sell
776
-5,972
-89% -$241K ﹤0.01% 5716
2019
Q4
$263K Buy
+6,748
New +$205K ﹤0.01% 5293

Other funds holding RLMD